Ireland must act quickly or lose chance to be leading player in AI, committee will hear
artificial intelligence
development, the chair of the new advisory council on the technology has said.
In a stark warning about the need to engage quickly with AI,
Dr Patricia Scanlon
, chair of the AI Advisory Council, has said Ireland needs urgent action across government to deal with the opportunities and risks.
Dr Scanlon's opening statement for a hearing of the Joint Committee on AI outlines the challenge ahead: 'Other countries are racing to become AI hubs. We need targeted action to stay competitive.
[
AI avisory group warns of potential for mass surveillance
Opens in new window
]
'Ireland can become Europe's preferred AI base, but only if we fundamentally change our approach to regulation and implementation. Tweaking won't work.'
READ MORE
Dr Scanlon is a leading expert with a PHD in AI. She is the founder and first chief executive of Soapbox, a global leader in voice AI for children.
Her statement to the committee emphasised the need for early action in that is fundamentally transforming work, learning, innovation and the functioning of society.
'This won't be easy or cheap, but needs immediate commitment to address critical priorities,' she said.
'Half-measures and incremental changes will leave Ireland behind. We need transformational investment and policy change now.
'Ireland's window to lead this transformation rather than be shaped by it is rapidly closing. The decisions we make in the coming months will be critical,' she said.
[
Why Greeks are in pole position when it comes to artificial intelligence
Opens in new window
]
Ms Scanlon outlined the upside and downside risks, both of which are immediate. The negative aspects include the erosion of privacy, job displacement, misinformation and negative impacts on safety and human dignity. However, she said, the second risk is inaction, which would have a detrimental impact on competitiveness, investment, healthcare and education.
'Let me be direct. Ireland's past successes in technology don't guarantee future success,' said Dr Scanlon.
The AI Advisory Council consists of 15 independent experts advising the Government on harnessing AI, protecting rights and building public trust. Dr Scanlon and her colleagues from the council will introduce the nature of their work to members of the committee, chaired by Fianna Fáil TD
Malcolm Byrne
, on Tuesday.
The critical priorities identified include serious regulatory reforms, establishing an AI observatory to track real-time impacts on jobs and skills, and supporting national AI literacy that spans education and workplace settings.
Ireland already has strong foundations including good levels of education, robust research and a culture of energetic start-ups, she said.
'However, other countries are racing to become AI hubs. We need targeted action to stay competitive. Ireland can become Europe's preferred AI base, but only if we fundamentally change our approach to regulation and implementation.
'Tweaking won't work. We need new regulatory capacity that's well-resourced and works quickly across sectors ... Regulation alone isn't enough. Investment must match the pace of AI.
'This isn't just about attracting business. Government must ensure AI delivers real benefits for society.'
[
Artificial intelligence already in use in many parts of public service as guidelines are announced
Opens in new window
]
Elsewhere, Dr Scanlon refers to the current limitations of the energy grid which have slowed the expansion of
data centres
– an area in need of significant investment in renewable energy, smart grid technology, and infrastructure. She also highlights the risk of AI replacing work previously done by humans.
'Even moderate job losses across multiple sectors could increase unemployment,' she says.
'We cannot predict the pace or scale, or if lost jobs will be replaced. We cannot be reactive. Ireland needs an AI observatory, a national system tracking real-time impacts on jobs and skills as they happen. Without it we're navigating tomorrow's changes with yesterday's map.'
Dr Scanlon has also emphasised the need for AI literacy across the Irish education system.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
7 hours ago
- Irish Times
Gareth Sheridan: Nutriband ‘will help a lot of people who are dealing with addiction and people who are dealing with pain'
Nutriband is a pharmaceutical company that was founded in Dublin in 2012 before relocating to Florida in 2016. Gareth Sheridan, who recently announced his intention to run for president and has stepped aside for three months as chief executive, is its founder. The company's lead product is Aversa, which it describes as 'abuse-deterrent transdermal technology', which incorporates aversive agents to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential, specifically opioids. Its first application is its abuse-deterrent fentanyl transdermal patch, which it is developing to provide clinicians and patients with extended-release chronic pain relief. It is awaiting regulatory clearance for this product in the US. The company has operations in Florida, Georgia, and North Carolina, and recently began its expansion back to Dublin. READ MORE What lightbulb moment prompted you to start-up in business? It was originally a thesis idea. I had noticed a patch that my dad wears and began wondering what other types of medications could be delivered that way that had not been explored yet. The thesis became a business plan, and Nutriband was registered in 2012. Describe your business model and what makes your business unique. We structured the company in a unique way, using capital markets and a public listing approach. We listed on the OTC Markets in 2016 and started using stock to purchase companies and technologies in place of cash. This helped us to avoid raising expensive early capital and retain a major equity stake in the company today, even after an eventual qualification to list on the Nasdaq (in New York) in 2010. We also do not develop new drug applications. We take existing generic medications and use our technologies to improve upon those and relaunch them as a branded product again. What is your greatest business achievement to date? Growing the company to a level where we qualified to list on the Nasdaq Stock Exchange and getting to ring the opening bell. What was your back-to-the-wall moment and how did you overcome it? We almost got sued by the SEC (The US Securities and Exchange Commission) for an accidental erroneous disclosure in one of our filings while on the OTC markets. At first, we thought it could be explained. However, it grew to the point where they were doubling down. We hired an excellent attorney with SEC experience and eventually settled the issue in a cease-and-desist, no-admit, no-deny agreement. This led to our back-to-the-wall moment, where, while running on fumes financially, we received a rejection from Nasdaq in our first application. After a couple of days of self-pity, we got back to work, raised some working capital with existing shareholders, and grew the company's equity by $7.5 million (€6.4 million) over the course of the next year. We reapplied to list again successfully. What moment would you cite as a turning point for the company? Credibility provided by our Nasdaq listing and subsequent partnership with Kindeva Drug Delivery (formerly 3M Drug Delivery), where Kindeva supplied their generic approved fentanyl patch for us to add our technology to. What were the best and the worst pieces of advice you received when starting out? The worst advice was that banks and institutions have your company's best interests at heart. I firmly believe that today, Wall Street is built on companies failing, not succeeding. Describe your growth funding path. We were reluctant to raise expensive capital early on and instead listed the company to use stock as an acquisition currency to grow. Our gamble on this paid off, and although we raised modest cash along the way, we were able to build Nutriband without any significant seed or angel rounds. We reached a market capitalisation of $120 million (its market value currently is about $75 million), and we have been able to maintain stable and steady control as a result of the minimal capital rounds. We turn down anywhere from $5 million to $15 million on a weekly basis from funds and institutions because we do not need it. We are not in the business of raising money, and having as little dilution as possible is a core focus for us as a company. How will your market look in three years and where would you like your business to be? For our first product, we are expected to reach annual revenues of $200 million. Our second product is independently estimated to have upwards of $135 million in yearly revenue. We are targeting the billion dollar club before the end of 2027. What are your annual revenues and profits? We are not yet profitable, as is typical with clinical development-stage companies. However, we also contract manufacture sports tapes and products for brands such as Reebok and KT Tape. Our target revenue from this source for the financial year to the end of January 2026 is $3 million * . This goes towards operational costs and reduces our clinical burn. Why have you decided to seek a nomination for the presidency? It's never been a more important or relevant time in our history for a young president, particularly with the average age just under 40. I would be hoping that having a younger president would help narrow the division we're seeing in the country at the moment and that we can work together to tackle the issues, particularly the housing crisis. The younger generation aren't feeling very enthusiastic that their voices are being heard. What impact will this move have on your business? The company is in very safe hands and the biggest asset at the company is the team. We've got a very definite plan and timeline between now and Christmas on what needs to be achieved. Whether I'm in there or not that timeline needs to be adhered to. The company is motoring along fine. Stepping aside is not something that I think will fundamentally affect the opportunity for the company. What happens if you win? There are mechanisms where I can put the shares into a trust. I would be very proud that it was a company that I started and be very keen to still follow the journey, just not as CEO. Nutriband as a whole is going to do a lot of will help a lot of people who are dealing with addiction and people who are dealing with pain. *An earlier version of this article stated a higher target figure for contract manufacturing, which has since been revised by the company.
Irish Times
8 hours ago
- Irish Times
Trump drops Ukraine ceasefire demand and suggests Putin plan could bring peace
US president Donald Trump on Saturday split from Ukraine and key European allies after his summit with Russian president Vladimir Putin , adopting Putin's plan for a sweeping peace agreement based on Ukraine ceding unoccupied territory to Russia, instead of the urgent ceasefire Trump had said he wanted before the meeting. Skipping ceasefire discussions would give Russia an advantage in the talks, which are expected to continue on Monday when President Volodymyr Zelenskiy of Ukraine visits Trump at the White House. It breaks from a strategy Trump and European allies, as well as Zelenskiy, had agreed to before the US-Russia summit in Alaska. Trump told European leaders that he believed a rapid peace deal could be negotiated if Zelenskiy agrees to cede the rest of the Donbas region to Russia, even those areas not occupied by Russian troops, according to two senior European officials briefed on the call. In return, Putin offered a ceasefire in the rest of Ukraine at current battle lines and a written promise not to attack Ukraine or any European country again, the senior officials said. He has broken similar promises before. READ MORE Trump had threatened stark economic penalties if Putin left the meeting without a deal to end the war, but, as European and Russian officials acknowledged, he suspended those threats in the wake of the summit. The American president's moves got a chilly reception in Europe, where leaders have time and again seen Trump reverse positions on Ukraine after speaking with Putin. Trump wrote on Truth Social early on Saturday that he spoke by phone to Zelenskiy and European leaders after his meeting with Putin. He said that 'it was determined by all that the best way to end the horrific war between Russia and Ukraine is to go directly to a Peace Agreement, which would end the war, and not a mere Ceasefire Agreement, which often times do not hold up.' European leaders made clear, publicly and privately, that was not the case. They issued a statement that did not echo Trump's claim that peace talks were preferable to a ceasefire. Britain, France, Germany and others welcomed Trump's efforts to stop the war but threatened to increase economic penalties on Russia 'as long as the killing in Ukraine continues'. Still, in public statements, the European leaders praised Trump – in mellower terms than normal – for his efforts to broker peace, and in particular for his pledge to involve the United States in guaranteeing Ukraine's security going forward. Giorgia Meloni , Italy's prime minister, said in a statement that Trump supported a collective-security clause that would allow Ukraine 'to benefit from the support of all its partners, including the US, ready to take action if it is attacked again'. Trump confirmed Zelenskiy's announcement earlier on Saturday that the Ukrainian president would come to the White House on Monday. If that visit goes well, Trump said, he would schedule another meeting with Putin. With Russia advancing on the battlefield, a ceasefire would give Ukraine relief from Moscow's attacks and deprive Putin of some leverage at the bargaining table. Before his meeting with Putin, Trump had agreed with European allies and Zelenskiy that no peace negotiations could begin without a ceasefire in place. Zelenskiy, who was left out of the summit, said in a statement that he and Trump would on Monday 'discuss all of the details regarding ending the killing and the war'. Trump, in an interview with Fox News host Sean Hannity after the summit, put the onus for securing peace on Zelenskiy. 'Now it is really up to President Zelenskiy to get it done,' he said. 'I would also say the European nations have to get involved a little bit.' Russia, which launched a full-scale invasion of Ukraine in 2022, has demanded that Ukraine cede a large part of its land, disarm, swear off joining Nato and change governments. This article originally appeared in The New York Times . 2025 The New York Times Company
Irish Times
13 hours ago
- Irish Times
The Irish Times view on Budget 2026: put the focus on what is important
Over the next couple of weeks, as the Autumn political season starts to kick in, debate on October's budget will get underway in earnest. As ever, there will be a cacophony of demands from interest groups and lobbyists, looking for more spending or lower taxes for their particular cause. The job of the Government, of course, is to look through the noise to what is important. Despite the generous amount of €9.4 billion set aside for budget measures, this will not be easy. Money will be quickly eaten up through spending pressures in providing State services. Plans to hike vital investment expenditure need to be allowed for. And the demands on the table already would take up the €1.5 billion set aside for tax reductions a few times over. Yet while the choices will be sharp in some areas, context is needed. This is not shaping up to be a 'tough' budget. The promised package is still nearly three times the size of the last pre-Covid budget in 2019. The first job of the Government, indeed, is to start returning annual budgets to more sustainable levels, reducing them from the huge spending rises required during Covid-19 and to tackle the cost-of-living crisis. Claims that households are still squeezed need to be met in two ways. One is by appropriate increases in welfare and other support packages. The other is by continuing to improve the provision of services in areas such as health, education and childcare. These are much more effective in the longer-term than another round of universal cash supports. But by engaging in a blatant pre-election manoeuvre last year to repeat these 'once-off' supports again, Ministers have created a rod for their own back this time around. READ MORE Statements from Ministers that there would be no cost-of-living package this time appear to have become more equivocal in recent weeks. But giving a lot of money out again through these payments to all households is an inefficient use of State cash. If the Government does not bring this process to an end in the first budget of its new term, then – barring a big squeeze on the State finances – it never will. The plan to increase vital State investment is a key reason why there needs to be some restraint elsewhere. Realistic budgeting for the provision of State services also needs to be restored, ending the annual overruns in areas like health. Relying on corporate tax to keep outperforming as a way to pay for spending coming in ahead of target each year is not a good strategy. The other reason for caution is the uncertainty faced due to the policies of Donald Trump. Despite the trade deal between the EU and US, the economic and political backdrop for Ireland remains risky and unpredictable. Having cash in reserve and pursuing a strategic approach have seldom looked more important.
